Abstract
Purpose of Review
The prevalence of HIV-1 in Indonesia is on a concerning upward trajectory, with a concurrent rise in the development of drug-resistant strains, challenging the efficacy of antiretroviral therapy (ART). Many mutations have been found in the pol gene that makes HIV resistant to ART. We aim to review the major drug resistance mutations (DRMs) of reverse transcriptase (RT) of pol gene in HIV-1 cases in Indonesia.
Recent Findings
A total of eleven articles reporting DRMs in HIV-1 subjects from various regions between 2015–2020 in Indonesia are included. The prevalence of major DRMs on the RT gene in studies included varies from 3.4% to 34%. The CRF01_AE subtype stands out as the predominant variant. Notably, the prevalence of major DRMs in ART-experienced individuals is 22.1%, while ART-naïve individuals show a lower rate of 4.4%. Among the RT gene mutations, M184I/V emerges as the most prevalent (10.5%) within the nucleos(t)ide reverse transcriptase inhibitors (NRTI) group, while K103N leads among the non-NRTI (NNRTI) group, with a frequency of 6.4%. Regionally, North Sulawesi records the highest prevalence of major DRMs in the RT gene at 21.1%, whereas Riau and Central Papua exhibit the lowest rates at 3.4%.
Summary
Significant variations in drug resistance mutations within the RT gene across Indonesian regions highlight the importance of closely monitoring and evaluating the effectiveness of current antiretroviral therapy (ART) regimens. Considerably, more studies are needed to understand better and overcome the emergence of DRMs on HIV-1 patients in Indonesia.
Similar content being viewed by others
References
“UNAIDS Country factsheets Indonesia 2022.” Accessed: Jun. 21, 2023. [Online]. Available: https://www.unaids.org/en/regionscountries/countries/indonesia
Kurniasari MD, Huruta AD, Tsai HT, Lee C-W. Forecasting future HIV infection cases: evidence from Indonesia. Soc Work Public Health. 2021;36(1):12–25. https://doi.org/10.1080/19371918.2020.1851332.
Hamers RL, de Wit TFR, Holmes CB. HIV drug resistance in low-income and middle-income countries. Lancet HIV. 2018;5(10):e588–96. https://doi.org/10.1016/S2352-3018(18)30173-5.
Nagata S, Imai J, Makino G, Tomita M, Kanai A. Evolutionary Analysis of HIV-1 Pol Proteins Reveals Representative Residues for Viral Subtype Differentiation. Front Microbiol 8, 2017, Accessed: Jun. 21, 2023. [Online]. Available: https://www.frontiersin.org/articles/https://doi.org/10.3389/fmicb.2017.02151
Cilento ME, Kirby KA, Sarafianos SG. Avoiding drug resistance in HIV reverse transcriptase. Chem Rev. 2021;121(6):3271–96. https://doi.org/10.1021/acs.chemrev.0c00967.
Bale MJ, Kearney MF. Review: HIV-1 phylogeny during suppressive antiretroviral therapy. Curr Opin HIV AIDS. 2019;14(3):188–93. https://doi.org/10.1097/COH.0000000000000535.
Hu W-S, Hughes SH. HIV-1 Reverse Transcription. Cold Spring Harb Perspect Med. 2012;2(10):a006882. https://doi.org/10.1101/cshperspect.a006882.
Rhee S-Y, Kassaye SG, Barrow G, Sundaramurthi JC, Jordan MR, Shafer RW. HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates. J Int AIDS Soc. 2020;23(9):e25611. https://doi.org/10.1002/jia2.25611.
Shafer RW, Kantor R, Gonzales MJ. The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors. AIDS Rev. 2000;2(4):211–28.
“Regulation of Ministry of Health Republic of Indonesia number 87 year 2014 concerning Antiretroviral Guideline (in Bahasa Indonesia), (2014).” Accessed: Jun. 26, 2023. [Online]. Available: https://siha.kemkes.go.id/portal/files_upload/Buku_Permenkes_ARV_Cetak.pdf
Gulick RM, Flexner C. Long-acting HIV drugs for treatment and prevention. Annu Rev Med. 2019;70(1):137–50. https://doi.org/10.1146/annurev-med-041217-013717.
“Fact Sheet: HIV Drug Resistance.” Accessed: Jun. 21, 2023. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/hiv-drug-resistance
Trotter AB, Hong SY, Srikantiah P, Abeyewickreme I, Bertagnolio S, Jordan MR. Systematic review of HIV drug resistance in Southeast Asia. AIDS Rev. 2013;15(3):162–70.
“HIV Drug Resistance Database.” Accessed: Oct. 19, 2023. [Online]. Available: https://hivdb.stanford.edu/pages/documentPage/NRTI_mutationClassification.html
“HIV Drug Resistance Database.” Accessed: Oct. 19, 2023. [Online]. Available: https://hivdb.stanford.edu/pages/documentPage/NNRTI_mutationClassification.html
Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. 2022;18(2):e1230. https://doi.org/10.1002/cl2.1230.
Khairunisa SQ, et al. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients. AIDS Res Hum Retroviruses. 2015;31(2):255–9. https://doi.org/10.1089/AID.2014.0221.
Kotaki T, et al. HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia. AIDS Res Ther. 2015;12:5. https://doi.org/10.1186/s12981-015-0046-y.
M. Q. Y. M et al. “Sero- and Molecular Epidemiology of HIV-1 in Papua Province, Indonesia,” Acta Medica Indones 2017;49(3) Art. no. 3.
Khairunisa SQ, et al. Genotypic characterization of human immunodeficiency virus type 1 prevalent in Kepulauan Riau, Indonesia. AIDS Res Hum Retroviruses. 2018;34(6):555–60. https://doi.org/10.1089/AID.2018.0040.
Indriati DW, et al. Appearance of drug resistance mutations among the dominant HIV-1 subtype, CRF01_AE in maumere, Indonesia. Curr HIV Res. 2018;16(2):158–66. https://doi.org/10.2174/1570162X16666180502114344.
Rachman BE, Khairunisa SQ, Witaningrum AM, Yunifiar MQ, Widiyanti P, Nasronudin. Prevalence of drug-resistant mutation among drug-treated HIV/AIDS inpatient in Airlangga University teaching hospital, Surabaya, Indonesia. IOP Conf Ser Earth Environ Sci. 2018;125(1):012003. https://doi.org/10.1088/1755-1315/125/1/012003.
Megasari NLA, et al. The emergence of HIV-1 transmitted drug resistance mutations among antiretroviral therapy-naive individuals in Buleleng, Bali, Indonesia. Acta Medica Indones. 2019;51(3):197–204.
Ueda S, Witaningrum AM, Khairunisa SQ, Kotaki T, null Nasronudin, Kameoka M. Genetic diversity and drug resistance of HIV-1 circulating in North Sulawesi, Indonesia. AIDS Res Hum Retroviruses. 2019;35(4):407–13. https://doi.org/10.1089/AID.2018.0221.
Khairunisa SQ, et al. Identification of HIV-1 subtypes and drug resistance mutations among HIV-1-infected individuals residing in Pontianak, Indonesia. Germs. 2020;10(4):174–83. https://doi.org/10.18683/germs.2020.1203.
Khairunisa SQ, et al. 2018–2019 Update on the Molecular Epidemiology of HIV-1 in Indonesia. AIDS Res Hum Retroviruses. 2020;36(11):957–63. https://doi.org/10.1089/aid.2020.0151.
Indriati DW et al. The dominance of crf01_ae and the emergence of drug resistance mutations among antiretroviral therapy-experienced, HIV-1-infected individuals in Medan, Indonesia. Acta Medica Indones. 2020;52(4) Art. no. 4.
“NNRTI Resistance Mutation Scores - HIV Drug Resistance Database.” Accessed: Jun. 26, 2023. [Online]. Available: https://hivdb.stanford.edu/dr-summary/mut-scores/NNRTI/
“NRTI Resistance Notes - HIV Drug Resistance Database.” Accessed: Jun. 26, 2023. [Online]. Available: https://hivdb.stanford.edu/dr-summary/resistance-notes/NRTI/
Gupta RK, et al. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet. 2012;380(9849):1250–8. https://doi.org/10.1016/S0140-6736(12)61038-1.
Chook JB, et al. Molecular detection of HIV-1 subtype B, CRF01_AE, CRF33_01B, and newly emerging recombinant lineages in Malaysia. Am J Trop Med Hyg. 2015;92(3):507–12. https://doi.org/10.4269/ajtmh.14-0681.
Angelis K, et al. Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia. J Infect Dis. 2015;211(11):1735–44. https://doi.org/10.1093/infdis/jiu666.
Dey SK, et al. Molecular epidemiology of HIV in Asia. HIV AIDS Rev. 2014;13(2):33–9. https://doi.org/10.1016/j.hivar.2014.02.003.
Chu M, et al. HIV-1 CRF01_AE strain is associated with faster HIV/AIDS progression in Jiangsu Province, China. Sci Rep. 2017;7:1570. https://doi.org/10.1038/s41598-017-01858-2.
Witaningrum AM, et al. Genotypic characterization of human immunodeficiency virus Type 1 derived from antiretroviral therapy-naive individuals residing in Sorong, West Papua. AIDS Res Hum Retroviruses. 2016;32(8):812–7. https://doi.org/10.1089/aid.2016.0054.
Foley B, Donegan E, Silitonga N, Wignall FS, Busch MP, Delwart EL. Importation of multiple HIV Type 1 strains into West Papua, Indonesia (Irian Jaya). AIDS Res Hum Retroviruses. 2001;17(17):1655–9. https://doi.org/10.1089/088922201753342068.
Ueda S et al. Transmission dynamics of HIV-1 subtype B strains in Indonesia. Sci Rep. 2019;9(1) Art. no. 1. https://doi.org/10.1038/s41598-019-50491-8
Polilli E, et al. Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature. J Med Case Rep. 2009;3:9132. https://doi.org/10.4076/1752-1947-3-9132.
Sehgal S, Pasricha N, Singh S. High rate of mutation K103N causing resistance to nevirapine in Indian children with acquired immunodeficiency syndrome. Indian J Med Microbiol. 2008;26(4):372–4. https://doi.org/10.4103/0255-0857.43583.
Diallo K, Götte M, Wainberg MA. Molecular impact of the M184V mutation in human immunodeficiency virus Type 1 reverse transcriptase. Antimicrob Agents Chemother. 2003;47(11):3377–83. https://doi.org/10.1128/AAC.47.11.3377-3383.2003.
“Regulation of Ministry of Health Republic of Indonesia number 23 year 2022 concerning Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome and Sexually Transmitted Infections (in Bahasa Indonesia), (2022).” Accessed: Dec. 04, 2023. [Online]. Available: https://peraturan.go.id/files/bn831-2022.pdf
“Regulation of Ministry of Health Republic of Indonesia number HK.01.07/MENKES/90/2019 concerning National Guideline of HIV Management (in Bahasa Indonesia), (2019).” Accessed: Dec. 04, 2023. [Online]. Available: https://siha.kemkes.go.id/portal/files_upload/PNPK_HIV_Kop_Garuda__1_.pdf
Chia HX, Tan SY, Ko KC, Tan RKJ, Lim J. HIV drug resistance in Southeast Asia: prevalence, determinants, and strategic management. J Public Health Emerg. 2022;6(0) Art. no. 0. https://doi.org/10.21037/jphe-22-5.
Steegen K, et al. Moderate levels of pre-treatment HIV-1 antiretroviral drug resistance detected in the first south african national survey. PLoS One. 2016;11(12):e0166305. https://doi.org/10.1371/journal.pone.0166305.
Jordan MR, et al. Update on world health organization HIV drug resistance prevention and assessment strategy: 2004–2011. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;54(Suppl 4):S245–9. https://doi.org/10.1093/cid/cis206.
World Health Organization, Global action plan on HIV drug resistance 2017–2021. Geneva: World Health Organization, 2017. Accessed: Jun. 26, 2023. [Online]. Available: https://apps.who.int/iris/handle/10665/255883
Manyana S, et al. Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings. AIDS Res Ther. 2023;20(1):9. https://doi.org/10.1186/s12981-023-00505-3.
Acknowledgements
The editors would like to thank Dr. Masanori Kameoka for handling the review of this manuscript.
Funding
S.J. has been funded by Manajemen Talenta, Badan Riset dan Inovasi Nasional, Indonesia. C.H.C.S. has been funded by a 2023 grant from the Fondazione Veronesi, Milan, Italy.
Author information
Authors and Affiliations
Contributions
Conceptualization, S.J.; F.S.T; N and M.N.M; writing—original draft preparation, S.J.; F.S.T; N; and U.S.A.M.; writing—review and editing, S.J.; F.S.T; N; U.S.A.M, C.H.C.S, and M.N.M; visualization, S.J. and U.S.A.M; All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Competing Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nurjannah, Jayanti, S., Tanoerahardjo, F.S. et al. Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review. Curr HIV/AIDS Rep 21, 31–39 (2024). https://doi.org/10.1007/s11904-023-00687-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11904-023-00687-5